×

Zomepirac and cardiovascular deaths

  • Author

    Inman WHW Rawson NSB

    Inman WHW Rawson NSB

  • Cite

    Lancet. 1983 Oct 15;2(8355):908

Yellow cards and green forms

  • Author

    Inman WH

    Inman WH

  • Cite

    Practitioner. 1983 Sep;227(1383):1443-9

Erythromycin estolate and jaundice

  • Author

    Inman WHW Rawson NSB

    Inman WHW Rawson NSB

  • Cite

    Br Med J (Clin Res Ed). 1983 Jun 18;286(6382):1954-5

Adverse reactions to new drugs

  • Author

    Inman WHW

    Inman WHW

  • Cite

    Br Med J (Clin Res Ed). 1983 Feb 26;286(6366):719-20

Prescription-event monitoring

  • Author

    Inman WH

    Mann RD

  • Cite

    Br Med J (Clin Res Ed). 1982 Sep 18;285(6344):809-10

Postmarketing surveillance of adverse drug reactions in general practice. II: Prescription-event monitoring at the University of Southampton

  • Author

    Inman WHW

    Inman WHW

  • Cite

    Br Med J (Clin Res Ed). 1981 Apr 11;282(6271):1216-7

Postmarketing surveillance of adverse drug reactions in general practice. I. Search for new methods

  • Author

    Inman WHW

    Inman WHW

  • Cite

    Br Med J (Clin Res Ed). 1981 Apr 4;282(6270):1131-2

Oral contraceptives and fatal subarachnoid haemorrhage

  • Author

    Inman WHW

    Inman WHW

  • Cite

    Br Med J. 1979 Dec 8;2(6203):1468-70

Risk of non-fatal cardiac failure and ischaemic heart disease with long acting beta 2 agonists

  • Author

    Mann RD Dunn NR Martin RM Freemantle SN

    Mann RD Dunn NR Martin RM Freemantle SN

  • Cite

    Thorax. 1998 Jul;53(7):558-62